Your browser doesn't support javascript.
loading
Fabrication of liposomal doxorubicin exhibiting ultrasensitivity against phospholipase A2 for efficient pulmonary drug delivery to lung cancers.
Tagami, Tatsuaki; Ando, Yuta; Ozeki, Tetsuya.
Afiliación
  • Tagami T; Drug Delivery and Nano Pharmaceutics, Graduate School of Pharmaceutical Sciences, Nagoya City University, 3-1 Tanabe-dori, Mizuho-ku, Nagoya, Aichi 467-8603, Japan.
  • Ando Y; Drug Delivery and Nano Pharmaceutics, Graduate School of Pharmaceutical Sciences, Nagoya City University, 3-1 Tanabe-dori, Mizuho-ku, Nagoya, Aichi 467-8603, Japan.
  • Ozeki T; Drug Delivery and Nano Pharmaceutics, Graduate School of Pharmaceutical Sciences, Nagoya City University, 3-1 Tanabe-dori, Mizuho-ku, Nagoya, Aichi 467-8603, Japan. Electronic address: ozekit@phar.nagoya-cu.ac.jp.
Int J Pharm ; 517(1-2): 35-41, 2017 Jan 30.
Article en En | MEDLINE | ID: mdl-27865984

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Doxorrubicina / Sistemas de Liberación de Medicamentos / Fosfolipasas A2 / Pulmón / Neoplasias Pulmonares / Antibióticos Antineoplásicos Idioma: En Revista: Int J Pharm Año: 2017 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Doxorrubicina / Sistemas de Liberación de Medicamentos / Fosfolipasas A2 / Pulmón / Neoplasias Pulmonares / Antibióticos Antineoplásicos Idioma: En Revista: Int J Pharm Año: 2017 Tipo del documento: Article